| ARCHETYPE ID | openEHR-EHR-CLUSTER.lymph_node_metastases.v0 |
|---|---|
| Concept | Lymph node metastases |
| Description | To record findings of tumour metastases in lymph nodes. |
| Use | To record detailed findings about lymph node metastases as part of microscopic examination of tissue. Use as a component archetype in the context of a suite of archetypes that make up a histopathology report ie OBSERVATION.lab_test.histopathology. |
| Misuse | Not designed to be used within any other archetype other than OBSERVATION.lab_test.histopathology. |
| Purpose | To record detailed findings of lymph node metastases as part of microscopic histopathological examination of tissue. |
| References | |
| Copyright | © openEHR Foundation |
| Authors | Author name: Dr Ian McNicoll Organisation: Ocean Informatics, Scotland Email: ian.mcnicoll@oceaninformatics.com Date originally authored: 2009-05-17 |
| Other Details Language | Author name: Dr Ian McNicoll Organisation: Ocean Informatics, Scotland Email: ian.mcnicoll@oceaninformatics.com Date originally authored: 2009-05-17 |
| Other Details (Language Independent) |
|
| Keywords | tumour, lymph node, metastases, pathology, histopathology, cancer, malignancy |
| Lifecycle | in_development |
| UID | f76df12a-08bd-4a73-be4c-bf7176001072 |
| Language used | en |
| Citeable Identifier | 1246.145.764 |
| Revision Number | 0.0.1-alpha |
| items | |
| Lymph node site name | Lymph node site name: The name for the lymph node site being reported. This may be a general location e.g. 'Axillary nodes', a relative site e.g. 'Sentinel nodes', 'Apical node', 'Regional nodes' or a individual node. |
| Lymph node site location | Lymph node site location: The anatomical location of the lymph node or site being reported. Include: openEHR-EHR-CLUSTER.anatomical_ openEHR-EHR-CLUSTER.anatomical_ |
| Tissue available | Tissue available: Has the appropriate lymph node tissue been made available for examination?
|
| Tumour involvement | Tumour involvement: Findings of lymph node involvement with tumour.
|
| Nature of involvement | Nature of involvement: Nature or grade of the tumour, if present.
|
| Route of involvement | Route of involvement: The route by which the tumour became involved in lymph node tissue.
|
| Number of nodes examined | Number of nodes examined: Number of nodes examined. min: >=0 |
| Number of nodes with tumour | Number of nodes with tumour: Number of nodes which show tumour involvement. min: >=0 |
| Extent of tumour | Extent of tumour: Extent of tumour expressed as a maximum length. Applies only to an individual node. Property: Length Units: >=0.0 mm |
| Extra-nodal extension | Extra-nodal extension: Findings related to extension of tumour external to the nodal capsule. |
| Extra-capsular extension | Extra-capsular extension: Findings of extension of tumour beyond a node capsule.
|
| Extent of extranodal tumour | Extent of extranodal tumour: Extent of extranodal tumour expressed as a maximum length. Property: Length Units: >=0.0 mm |
| Description | Description: A text description of lymph node involvement by tumour. |
| Marker dye uptake | Marker dye uptake: Findings of whether marker dye has been taken up by the lymph node or lymph node group. |
| Lymph node details | Lymph node details: Further details of lymph node metastasis at this site e.g individual nodes or further levels. Include: openEHR-EHR-CLUSTER.lymph_ openEHR-EHR-CLUSTER.lymph_ Exclude: All not explicitly included archetypes |
| Radioactivity count | Radioactivity count: Radioactivity count measured after use of radiocolloid. Property: Frequency Units:
|
| Other contributors | Sam Heard, Ocean Informatics, Australia (openEHR Editor) Sabine Leh, Haukeland University Hospital, Department of Pathology, Norway (openEHR Editor) Ian McNicoll, freshEHR Clinical Informatics, United Kingdom (openEHR Editor) David Rowed, VAMC Clinic, Australia (openEHR Editor) Silje Ljosland Bakke, Nasjonal IKT HF, Norway John Tore Valand, Helse Bergen HF, Norway |
| Translators |
|